Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 5, 1996 - Issue 2
Submit an article Journal homepage
6
Views
0
CrossRef citations to date
0
Altmetric
Original Article

Monthly Update: Oncologic, Endocrine & Metabolic: What is the most appropriate drug therapy for carcinoma of the prostate? A discussion with an emphasis on the concept of maximal androgen blockade

Michael Jarman Cancer Research Campaign Centre for Cancer Therapeutics at the Institute of Cancer Research, Cancer Research Campaign Laboratories, 15 Cotswold Road, Sutton, Surrey, SM2 5NG
Pages 245-247 | Published online: 03 Mar 2008

References

  • LUNGLMAYR G AND THE INTERNATIONAL CASODEX STUDY GROUP: Efficacy and tolerability of Casodex in patients with advanced prostate cancer. Anti-Cancer Drugs (1995) 6:508–513.
  • BROGDEN RN, CLISSOLD SP: Flutamide, a preliminary review of its pixarmacodynamie and pharmacokinetic properties, and therapeutic efficacy in advanced pro-static cancer. Drugs (1989) 38:185–203.
  • HARRIS MG, COLEMAN SG, FAULDS D, CHRISP P: Nib]:tamide: a review of its pharmacodynamic and pharma-cokinetic properties and therapeutic efficacy in prostate cancer. Drugs Aging (1993) 3:9–25.
  • PROSTATE CANCER TRIALISTS' COLLABORATIVE GROUPMaximum androgen blockade in advanced prostatic cancer: an overview of 22 randomised trials with 3283 deaths in 5710 patients. The Lancet (1995) 346:265–269.
  • COX RL, CRAWFORD ED: Estrogens in the treatment of prostate cancer. J. Urol. (1995) 154:1991–1998.
  • LABRIE F, DUPONT A, BELANGER A, CUSAN L, LACOUR-CIERE Y, MONFEI IF. G, LABERGE JG, EMOND JP, FAZEKAS AT, RAYNAUD JP: New hormonal therapy in prostate carcinoma. Combined treatment with an LIIR11 agonist and an antiandrogen. din. Invest. Med. (1982) 5:267–275.
  • CRAWFORD ED, BLUMENSTEIN BA, GOODMAN PJ, DAVIS MA, EISENBERGER MA, VICLEOD DG, SPAULDING JT, BEN-SON R, DORR FA: Leuprolide with and without flutamide In advanced prostate cancer. Cancer (1990) 66:1039–1044.
  • CRAWFORD ED, DEANTONIO EP, LABRIE F, SCHRODER FH, GELLER J: Endocrine therapy of prostate cancer: optimal form and appropriate timing. J. Clin. Endocrinol. Metab. (1995) 80:1062–1078.
  • RANA A, HABIB FK, HALLIDAY P, ROSS M, WILD R, ELTONRA, CHISHOLM GD: A case for synchronous reduction of testicular androgen, adrenal androgen and prolactin for the treatment of advanced carcinoma of the pros-tate. Eur. J. Cancer (1995) 314:871–875.
  • DECENSI A, TORRISI R, FONTANA V, MARRONI P,PADOVANI P, GUARNERI D, MINUTO F, BOCCARDO F: Long-term endocrine effects of administration of either a non-steroidal antiandrogen or a luteinizing hormone-releasing hormone agonist in men with prostate can-cer. Ada Endocrinologica (1993) 129:315–321.
  • POTTER GA, BARRIE SE, JARMAN M, ROWLANDS MG: Novel steroidal inhibitors of human cytochrome P45 Om ( 17 a-hydroxylas e-C17,2o- ly as e): potential agents for the treatment of prostatic cancer. J. Med. Chem (1995) 38:2463–2471.
  • ROWLANDS MG, BARRIE SE, CHAN F, HOUGHTON J, JARMAN M, MCCAGUE R, POTTER GA: Esters of 3-pyridyl-acetic acid that combine potent inhibition of 17a-hy-droyrylase/C17,2o-lyase (cytochrome P45017a) with resistance to esterase hydrolysis. J. Med. Chem. (1995) 38:4191–4197.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.